For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
meet the exacting demands of cell and gene therapy applications, our premium grade .
From basic to translational research and clinical applications, cell culture is an essential technique that underpins the generation of promising cell and gene therapies. Since the quality of cytokines and growth factors can significantly influence the properties and function of cultured cells, these bioactive proteins must be produced to the highest standards to ensure the same reproducible results over a 5-15 years development timeline. This will enable cell and gene therapies to transition smoothly from early discovery to clinical development.
To help you meet the ongoing cell and gene therapy production demands today and in the future, Abcam has launched a range of recombinantly produced premium grade cytokines and growth factors with class-leading consistency. The consistent performance of Abcam’s premium grade bioactive proteins enables a smooth transition from research to clinical development, saving your time and resources. Their batch-to-batch consistency also allows these proteins to fulfill additional applications efficiently across a wide range of cell culture discovery and basic research techniques, including in vivo and in vitro assay development, compound screening, and structural studies.
This white paper demonstrates:
Written by Dr Eileen Paul